Earnings Ahead

CRL - Charles River Laboratories International, Inc.

204.33 -1.97 -0.96

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.

About

Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employe


Headquarters

Wilmington, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CRL



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Charles River Laboratories Non-GAAP EPS of $2.46 beats by $0.06, revenue of $1.01B beats by $18.75M
  • Charles River Laboratories Q4 2023 Earnings Preview
  • Charles River Laboratories launches Rep/Cap plasmid
  • Cell and gene therapy market to reach $80B by 2029: report
  • Charles River CEO buys ~$1M worth of stock
  • Charles River Laboratories Non-GAAP EPS of $2.72 beats by $0.35, revenue of $1.03B beats by $30M
  • Charles River Laboratories Q3 2023 Earnings Preview
  • Charles River falls on Investor Day amid growth concerns
  • Catalyst watch: Microsoft, Amazon, Oracle, and Intel to Hold High-Profile Events
  • Charles River inks deal with Related Sciences to drive AI-led drug discovery
  • Charles River Laboratories announces plasmid manufacturing collaboration with Fondazione Telethon
  • Charles River Laboratories beats Q2 top and bottom line estimates; raises FY23 outlook
  • Charles River Laboratories Q2 2023 Earnings Preview
  • Charles River Labs downgraded to neutral at Citi on few catalysts
  • What’s next for clinical research firms after pandemic boom?
  • Charles River Labs in collaboration with Korean biotech
  • Charles River Laboratories Non-GAAP EPS of $2.78 beats by $0.19, revenue of $1.03B beats by $43.94M
  • Charles River Laboratories Q1 2023 Earnings Preview
  • Charles River Laboratories hits 52-week low
  • Maryland pushes for alternatives to animal-based medical research
PEERS
/XLV

XLV

Date Price Open High Low Vol Change ER
Oct 9, 2023 193.07 190.95
194.03
190.93
228K -0.2%
Oct 6, 2023 193.46 189.64
195.56
188.79
439K 1.21%
Oct 5, 2023 191.15 189.87
192.3
187.25
481K 0.13%
Oct 4, 2023 190.9 192.42
193.76
187.01
415K -0.41%
Oct 3, 2023 191.68 191.59
193.01
190.59
317K -0.88%
 
Oct 2, 2023 193.39 195.42
195.42
191
524K -1.32%
Sep 29, 2023 195.98 198.04
198.9
195.47
366K 0.34%
Sep 28, 2023 195.31 194.06
196.76
192.74
434K 0.19%
Sep 27, 2023 194.94 195.07
195.27
191.1
400K 0.26%
Sep 26, 2023 194.44 196.55
197.98
194.2
336K -1.58%
Sep 25, 2023 197.57 198.26
199
196.14
395K -1.03%
Sep 22, 2023 199.62 196.07
202.71
192.4
765K 0.74%
Sep 21, 2023 198.15 205
205
193.58
1.2M -5.02%
Sep 20, 2023 208.63 210.2
213.04
207.88
725K 0.05%
Sep 19, 2023 208.53 209.89
211.21
208.46
775K -0.97%
Sep 18, 2023 210.57 207.37
211.98
205.99
633K 1.29%
Sep 15, 2023 207.88 207.31
212.6
205.72
629K 0.06%
Sep 14, 2023 207.76 205.85
208.15
201.7
544K 2.04%
Sep 13, 2023 203.61 195.06
205.03
195.06
609K 3.30%
Sep 12, 2023 197.11 198.88
199.92
195.04
519K -1.28%
Sep 11, 2023 199.66 200.75
203.26
199.54
419K -0.04%
Sep 8, 2023 199.74 203.59
204.08
198.61
556K -2.28%
Sep 7, 2023 204.39 202.56
205.34
201.8
367K -0.02%
Sep 6, 2023 204.44 204.05
206.14
203.56
263K 0.07%
Sep 5, 2023 204.29 209.06
209.06
204.2
370K -2.54%
Sep 1, 2023 209.62 209.35
210.39
206.93
282K 1.35%
Aug 31, 2023 206.82 209.7
211.25
206.56
400K -1.36%
Aug 30, 2023 209.68 204.63
210.9
204.63
355K 2.84%
Aug 29, 2023 203.89 199.71
204.33
198.96
290K 2.58%
Aug 28, 2023 198.76 200.84
202.28
197.89
313K -0.81%
Aug 25, 2023 200.39 198.7
202.16
198.7
249K 0.89%
Aug 24, 2023 198.62 202.41
203.23
198.4
389K -1.67%
Aug 23, 2023 202 201.8
203.4
201.24
279K 0.89%
Aug 22, 2023 200.22 201
202.61
198.88
290K -0.34%
Aug 21, 2023 200.91 199.03
201.63
198.66
310K 1.01%
Aug 18, 2023 198.9 197.63
199.7
196.85
415K -0.49%
Aug 17, 2023 199.87 202.11
203.19
199.49
447K -1.04%
Aug 16, 2023 201.97 207.89
208.74
201.83
584K -3.86%
Aug 15, 2023 210.07 215.48
216.27
209.46
557K -3.15%
Aug 14, 2023 216.9 212.62
217.3
212.62
340K 1.14%
Aug 11, 2023 214.46 217.34
217.72
212.55
492K -1.45%
Aug 10, 2023 217.61 216.02
217.81
214
776K 0.84%
Aug 9, 2023 215.8 212.27
218.83
210.98
945K 4.64%
Aug 8, 2023 206.24 203.85
206.62
201.91
552K 0.47%
Aug 7, 2023 205.28 207.1
208
204.12
606K -0.78%
Aug 4, 2023 206.9 201.67
209.22
201.03
678K 2.66%
Aug 3, 2023 201.54 205.88
206.32
201.52
626K -2.17%
Aug 2, 2023 206.01 207.62
208.5
204.24
383K -1.58%
Aug 1, 2023 209.31 208
210.71
206.81
264K -0.11%
Jul 31, 2023 209.54 210.91
212.98
209.31
317K -0.45%
Jul 28, 2023 210.49 211.24
211.48
205.86
409K 0.95%
Jul 27, 2023 208.51 214
215.43
208.06
278K -2.12%
Jul 26, 2023 213.03 211.27
213.99
209.24
498K 0.93%
Jul 25, 2023 211.07 205.1
212.38
205.1
408K 1.84%
Jul 24, 2023 207.25 201.88
207.32
201.88
285K 0.42%
Jul 21, 2023 206.38 202.02
207.23
197.55
689K 1.17%
Jul 20, 2023 203.99 205.39
205.39
202.14
321K -0.01%
Jul 19, 2023 204.02 201.82
205.1
201.68
767K 1.33%
Jul 18, 2023 201.34 208.5
208.5
200.5
854K -3.82%
Jul 17, 2023 209.34 207.65
210.16
204.26
302K 0%